Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses

The approval of the first oncolytic virus for the treatment of metastatic melanoma and the compiling evidence that the use of oncolytic viruses can enhance cancer immunotherapies targeted against various immune checkpoint proteins has attracted great interest in the field of cancer virotherapy. We h...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Mol Ther
Main Authors: Ylösmäki, Erkko, Malorzo, Cristina, Capasso, Cristian, Honkasalo, Oona, Fusciello, Manlio, Martins, Beatriz, Ylösmäki, Leena, Louna, Antti, Feola, Sara, Paavilainen, Henrik, Peltonen, Karita, Hukkanen, Veijo, Viitala, Tapani, Cerullo, Vincenzo
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Gene & Cell Therapy 2018
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6127500/
https://ncbi.nlm.nih.gov/pubmed/30005865
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2018.06.008
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares